Regulatory Fate of Cancer Indications in the European Union After Accelerated Approval in the US.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2024.5145
Abstract: This cohort study investigates the regulatory fate in the European Union for drugs that received accelerated approval for cancer indications in the US. read more here.
Keywords: cancer indications; regulatory fate; european union; accelerated approval ... See more keywords